IDSI wins contract with Canadian firm

Article

Breast imaging device developer Imaging Diagnostic Systems has received an order for its CT Laser Mammography system (CTLM), a work-in-progress device that uses infrared laser light to image breast tissue. The company signed an agreement at the RSNA show

Breast imaging device developer Imaging Diagnostic Systems has received an order for its CT Laser Mammography system (CTLM), a work-in-progress device that uses infrared laser light to image breast tissue. The company signed an agreement at the RSNA show last month with Cycle of Life Technologies of Toronto for two of the units. The deal should bring in approximately $500,000, the first revenues generated by the Fort Lauderdale, FL, firm since it was established. IDSI expects to deliver the devices during the first quarter of next year.

The agreement also covers the delivery of two more CTLM devices once the first order has been fulfilled, as well as a distribution contract for 50 systems over the next two years. Cycle of Life Technologies supplies medical services and equipment to clients in Canada, Europe, South Africa, and the Middle East.

Since IDSI has yet to apply for premarket approval from the Food and Drug Administration for CTLM, the company must obtain an export certificate from the agency before it can ship the system. The certificate application must include letters from each country Cycle of Life Technologies services stating that the country will accept a non-FDA-approved device for import.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.